Cargando…
Radiotherapy and Immunotherapy for Head and Neck Cancer: Current Evidence and Challenges
Immune checkpoint inhibitors (ICI) have revolutionized cancer treatment over the past decade. However, although the immune landscape suggests a strong rationale for the use of these agents in patients with head and neck squamous cell carcinoma, the available clinical evidence indicates that most pat...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7886974/ https://www.ncbi.nlm.nih.gov/pubmed/33614492 http://dx.doi.org/10.3389/fonc.2020.608772 |